Status:
UNKNOWN
Dose of Remi in Children
Lead Sponsor:
Zhihong LU
Conditions:
Anesthesia
Eligibility:
All Genders
3-12 years
Phase:
NA
Brief Summary
Remimazolam has demonstrated the potential as a valuable medication for procedural sedation and general anesthesia. However, the effective dosage of remimazolam in pediatric patients is still unknown.
Eligibility Criteria
Inclusion
- age from 3 to 12 years old
- patients scheduled for surgery under general anesthesia
Exclusion
- American Society of Anesthesiologists status \>=Ⅲ
- Body mass index\>=28kg/m2
- patients who cannot cooperate with intravenous anesthesia induction
- patients with risk of difficult airway
- patients who are allergic to benzodiazepines
- patients with delayed neurologic function
Key Trial Info
Start Date :
August 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 10 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05990673
Start Date
August 10 2023
End Date
September 10 2023
Last Update
August 14 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.